open access

Ahead of print
Review paper
Published online: 2023-10-12
Get Citation

Endoscopic alternatives to classic surgical fundoplication in the treatment of gastroesophageal reflux disease

Michał Miciak1, Krzysztof Jurkiewicz1, Mariusz Chabowski234
Affiliations
  1. Student Research Club No. 180, Faculty of Medicine, Wroclaw Medical University, Wroclaw, Poland (Studenckie Koło Naukowe nr 180, Wydział Lekarski, Uniwersytet Medyczny we Wrocławiu, Wrocław, Polska), Poland
  2. Department of Nursing and Obstetrics, Faculty of Health Science, Wroclaw Medical University, Wroclaw, Poland (Katedra Pielęgniarstwa i Położnictwa, Wydział Nauk o Zdrowiu, Uniwersytet Medyczny we Wrocławiu, Wrocław, Polska), Poland
  3. Department of Surgery, 4th Military Teaching Hospital, Wroclaw, Poland (Klinika Chirurgiczna, 4 Wojskowy Szpital Kliniczny, Wrocław, Polska), Poland
  4. Department of Clinical Surgical Sciences, Faculty of Medicine, Wroclaw University of Science and Technology, Wroclaw, Poland (Katedra Nauk Klinicznych Zabiegowych, Wydział Medyczny, Politechnika Wrocławska, Wrocław, Polska)

open access

Ahead of print
Review articles
Published online: 2023-10-12

Abstract

Gastroesophageal reflux disease (GERD) is one of the most common gastrointestinal disorders in the modern world. Its onset is predisposed by factors related to poor lifestyle. Treatment of GERD consists of pharmacotherapy or surgery. The classic procedure is Nissen fundoplication. The development of endoscopy has enabled the use of new treatment methods that provide faster patient recovery with efficacy comparable to fundoplication. These methods include TIF (transoral incisionless fundoplication), the Stretta procedure (use of radiofrequency energy), injection of strengthening polymers and implantation of prostheses or anti-reflux stimulators. The TIF procedure is an endoscopic mirroring of fundoplication, the Stretta procedure is designed to reduce the relaxation of the lower oesophageal sphincter. Some polymers and prostheses have had promising therapeutic results but have been withdrawn due to complications, while others are expected to be used in the future. Endoscopic methods are constantly being improved based on the results of clinical trials. This study aims to present selected examples.

Abstract

Gastroesophageal reflux disease (GERD) is one of the most common gastrointestinal disorders in the modern world. Its onset is predisposed by factors related to poor lifestyle. Treatment of GERD consists of pharmacotherapy or surgery. The classic procedure is Nissen fundoplication. The development of endoscopy has enabled the use of new treatment methods that provide faster patient recovery with efficacy comparable to fundoplication. These methods include TIF (transoral incisionless fundoplication), the Stretta procedure (use of radiofrequency energy), injection of strengthening polymers and implantation of prostheses or anti-reflux stimulators. The TIF procedure is an endoscopic mirroring of fundoplication, the Stretta procedure is designed to reduce the relaxation of the lower oesophageal sphincter. Some polymers and prostheses have had promising therapeutic results but have been withdrawn due to complications, while others are expected to be used in the future. Endoscopic methods are constantly being improved based on the results of clinical trials. This study aims to present selected examples.

Get Citation

Keywords

gastroesophageal reflux disease; fundoplication; endoscopy; gastroplasty; gastroesophageal junction

About this article
Title

Endoscopic alternatives to classic surgical fundoplication in the treatment of gastroesophageal reflux disease

Journal

Chirurgia Polska (Polish Surgery)

Issue

Ahead of print

Article type

Review paper

Published online

2023-10-12

Page views

208

Article views/downloads

179

Keywords

gastroesophageal reflux disease
fundoplication
endoscopy
gastroplasty
gastroesophageal junction

Authors

Michał Miciak
Krzysztof Jurkiewicz
Mariusz Chabowski

References (77)
  1. Clarrett DM, Hachem C. Gastroesophageal Reflux Disease (GERD). Mo Med. 2018; 115(3): 214–218.
  2. Maret-Ouda J, Markar SR, Lagergren J. Gastroesophageal Reflux Disease: A Review. JAMA. 2020; 324(24): 2536–2547.
  3. El-Serag HB, Sweet S, Winchester CC, et al. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2014; 63(6): 871–880.
  4. Mohiuddin AK, Mohiuddin AK. Alternative Treatments for Minor GI Ailments. Innov Pharm. 2019; 10(3).
  5. Velagala NR, Velagala VR, Lamture Y. The Spectrum of Treatment Modalities for Gastroesophageal Reflux Disease (GERD): A Narrative Review. Cureus. 2022; 14(12): e32619.
  6. Nasrollah L, Maradey-Romero C, Jha LK, et al. Naps are associated more commonly with gastroesophageal reflux, compared with nocturnal sleep. Clin Gastroenterol Hepatol. 2015; 13(1): 94–99.
  7. Sandhu DS, Fass R. Current Trends in the Management of Gastroesophageal Reflux Disease. Gut Liver. 2018; 12(1): 7–16.
  8. Poh CH, Navarro-Rodriguez T, Fass R. Review: treatment of gastroesophageal reflux disease in the elderly. Am J Med. 2010; 123(6): 496–501.
  9. Yamasaki T, O'Neil J, Fass R. Update on Functional Heartburn. Gastroenterol Hepatol (N Y). 2017; 13(12): 725–734.
  10. Patti MG. An Evidence-Based Approach to the Treatment of Gastroesophageal Reflux Disease. JAMA Surg. 2016; 151(1): 73–78.
  11. Allende DS, Yerian LM. Diagnosing gastroesophageal reflux disease: the pathologist's perspective. Adv Anat Pathol. 2009; 16(3): 161–165.
  12. Hinder RA, Filipi CJ, Wetscher G, et al. Laparoscopic Nissen fundoplication is an effective treatment for gastroesophageal reflux disease. Ann Surg. 1994; 220(4): 472–81; discussion 481.
  13. Seeras K, Bittar K, Siccardi MA. Nissen Fundoplication. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. ; 2022: Jan.
  14. Du X, Wu JM, Hu ZW, et al. Laparoscopic Nissen (total) versus anterior 180° fundoplication for gastro-esophageal reflux disease: A meta-analysis and systematic review. Medicine (Baltimore). 2017; 96(37): e8085.
  15. Zaninotto G, Molena D, Ancona E, et al. A prospective multicenter study on laparoscopic treatment of gastroesophageal reflux disease in Italy : Type of surgery, conversions, complications, and early results. Surg Endosc. 2000; 14(3): 282–288.
  16. Richardson WS, Gorham JK, Neal N, et al. Endoscopic Treatment of Gastroesophageal Reflux Disease. Adv Surg. 2022; 56(1): 205–227.
  17. https://en.wikipedia.org/wiki/Nissen_fundoplication. [accessed 3 Mar, 2023].
  18. Chen YK. Endoscopic suturing devices for treatment of GERD: too little, too late? Gastrointest Endosc. 2005; 62(1): 44–47.
  19. Lo WK, Mashimo H. Critical Assessment of Endoscopic Techniques for Gastroesophageal Reflux Disease. J Clin Gastroenterol. 2015; 49(9): 720–724.
  20. Raphael KL, Walsh P, Benias PC. Innovations in Endoscopic Therapy for Gastroesophageal Reflux Disease. Gastrointest Endosc Clin N Am. 2020; 30(2): 291–307.
  21. Ihde GM. The evolution of TIF: transoral incisionless fundoplication. Therap Adv Gastroenterol. 2020; 13: 1756284820924206.
  22. Thomson M, Fraser C. Endoscopic approaches to the treatment of gastroesophageal reflux disease. Practical Pediatric Gastrointestinal Endoscopy. 2021: 249–260.
  23. Jobe BA, O'Rourke RW, McMahon BP, et al. Transoral endoscopic fundoplication in the treatment of gastroesophageal reflux disease: the anatomic and physiologic basis for reconstruction of the esophagogastric junction using a novel device. Ann Surg. 2008; 248(1): 69–76.
  24. Lee DP, Chang KJ. Endoscopic Management of GERD. Dig Dis Sci. 2022; 67(5): 1455–1468.
  25. Mittal RK, Zifan A, Kumar D, et al. Functional morphology of the lower esophageal sphincter and crural diaphragm determined by three-dimensional high-resolution esophago-gastric junction pressure profile and CT imaging. Am J Physiol Gastrointest Liver Physiol. 2017; 313(3): G212–G219.
  26. Bell RCW, Freeman K, Heidrick R, et al. Transoral incisionless fundoplication demonstrates durability at up to 9 years. Therap Adv Gastroenterol. 2021; 14: 17562848211004827.
  27. Bell RCW, Kurian AA, Freeman KD. Laparoscopic anti-reflux revision surgery after transoral incisionless fundoplication is safe and effective. Surg Endosc. 2015; 29(7): 1746–1752.
  28. Bomman S, Ghafoor A, Malashanka S, et al. S1022 Safe Implementation of Transoral Incisionless Fundoplication as a New Technique in a Tertiary Care Center. American Journal of Gastroenterology. 2021; 116(1): S486–S486.
  29. Ihde GM, Pena C, Scitern C, et al. pH Scores in Hiatal Repair with Transoral Incisionless Fundoplication. JSLS. 2019; 23(1).
  30. https://consultqd.clevelandclinic.org/innovative-endoscopic-treatment-for-gerd-now-available/[accessed 3 Mar, 2023].
  31. Franciosa M, Triadafilopoulos G, Mashimo H. Stretta Radiofrequency Treatment for GERD: A Safe and Effective Modality. Gastroenterol Res Pract. 2013; 2013: 783815.
  32. Auyang ED, Carter P, Rauth T, et al. SAGES Guidelines Committee. SAGES clinical spotlight review: endoluminal treatments for gastroesophageal reflux disease (GERD). Surg Endosc. 2013; 27(8): 2658–2672.
  33. Triadafilopoulos G. Stretta: a valuable endoscopic treatment modality for gastroesophageal reflux disease. World J Gastroenterol. 2014; 20(24): 7730–7738.
  34. Leeds S, Reavis K. Endolumenal therapies for gastroesophageal reflux disease. Gastrointest Endosc Clin N Am. 2013; 23(1): 41–51.
  35. Sowa P, Samarasena JB. Nonablative Radiofrequency Treatment for Gastroesophageal Reflux Disease (STRETTA). Gastrointest Endosc Clin N Am. 2020; 30(2): 253–265.
  36. Arts J, Bisschops R, Blondeau K, et al. A double-blind sham-controlled study of the effect of radiofrequency energy on symptoms and distensibility of the gastro-esophageal junction in GERD. Am J Gastroenterol. 2012; 107(2): 222–230.
  37. Ma L, Li T, Liu G, et al. Stretta radiofrequency treatment vs Toupet fundoplication for gastroesophageal reflux disease: a comparative study. BMC Gastroenterol. 2020; 20(1): 162.
  38. Richards WO, Houston HL, Torquati A, et al. Paradigm shift in the management of gastroesophageal reflux disease. Ann Surg. 2003; 237(5): 638–47; discussion 648.
  39. He S, Xu F, Xiong X, et al. Stretta procedure versus proton pump inhibitors for the treatment of nonerosive reflux disease: A 6-month follow-up. Medicine (Baltimore). 2020; 99(3): e18610.
  40. Fanous M, Jaehne A, Williams S. The Role of Transoral Incisionless Fundoplication After the Stretta Procedure. Am Surg. 2021; 87(12): 1986–1988.
  41. Kurlander JE, Kennedy JK, Rubenstein JH, et al. Patients' Perceptions of Proton Pump Inhibitor Risks and Attempts at Discontinuation: A National Survey. Am J Gastroenterol. 2019; 114(2): 244–249.
  42. Endoscopic antireflux procedures - Scientific Figure on ResearchGate. Available from: https://www.researchgate.net/figure/Overview-of-the-Stretta-catheter-placed-at-the-gastro-oesophageal-junction-for_fig2_8462443. [accessed 3 Mar, 2023].
  43. Mann R, Gajendran M, Perisetti A, et al. Advanced Endoscopic Imaging and Interventions in GERD: An Update and Future Directions. Front Med (Lausanne). 2021; 8: 728696.
  44. Kushner BS, Awad MM, Mikami DJ, et al. Endoscopic treatments for GERD. Ann N Y Acad Sci. 2020; 1482(1): 121–129.
  45. Quader F, Gyawali C. 7RECENT Advances in Endoscopic Treatments for Gastroesophageal Reflux Disease. Current Treatment Options in Gastroenterology. 2020; 18(3): 504–517.
  46. Cohen LB, Johnson DA, Ganz RA, et al. Enteryx implantation for GERD: expanded multicenter trial results and interim postapproval follow-up to 24 months. Gastrointest Endosc. 2005; 61(6): 650–658.
  47. Devière J, Costamagna G, Neuhaus H, et al. Nonresorbable copolymer implantation for gastroesophageal reflux disease: a randomized sham-controlled multicenter trial. Gastroenterology. 2005; 128(3): 532–540.
  48. De Moura EG, Sallum RAA, Nasi A, et al. Endoscopic polymer injection and endoluminal plication in treatment of gastroesophageal reflux disease: evaluation of long-term results. Endosc Int Open. 2018; 6(5): E630–E636.
  49. Helo N, Wu A, Moon E, et al. Visceral artery embolization after endoscopic injection of Enteryx for gastroesophageal reflux disease. J Radiol Case Rep. 2014; 8(9): 21–24.
  50. Ganz RA, Fallon E, Wittchow T, et al. A new injectable agent for the treatment of GERD: results of the Durasphere pilot trial. Gastrointest Endosc. 2009; 69(2): 318–323.
  51. Wang H. A Review of the Effects of Collagen Treatment in Clinical Studies. Polymers (Basel). 2021; 13(22).
  52. Lemperle G. Gastroesophageal Reflux Disease (GERD): An Overview of Current Minimal-Invasive Treatment Potentials. Am J Biomed Sci & Res. 2019; 2(6): 253–264.
  53. Lemperle G, Lappin PB, Stone C, et al. Urethral bulking with polymethylmethacrylate microspheres for stress urinary incontinence: tissue persistence and safety studies in miniswine. Urology. 2011; 77(4): 1005.e1–1005.e7.
  54. Pandolfino JE, Krishnan K. Do endoscopic antireflux procedures fit in the current treatment paradigm of gastroesophageal reflux disease? Clin Gastroenterol Hepatol. 2014; 12(4): 544–554.
  55. Feretis C, Benakis P, Dimopoulos C, et al. Endoscopic implantation of Plexiglas (PMMA) microspheres for the treatment of GERD. Gastrointest Endosc. 2001; 53(4): 423–426.
  56. Martin K, Emil S, Bernard C, et al. Dextranomer hyaluronic acid copolymer effects on gastroesophageal junction. J Pediatr Gastroenterol Nutr. 2014; 58(5): 593–597.
  57. Molitierno JA, Scherz HC, Kirsch AJ, et al. Endoscopic treatment of vesicoureteral reflux using dextranomer hyaluronic acid copolymer. J Pediatr Urol. 2008; 4(3): 221–228.
  58. Fockens P. Gatekeeper Reflux Repair System: technique, pre-clinical, and clinical experience. Gastrointest Endosc Clin N Am. 2003; 13(1): 179–189.
  59. Yew KC, Chuah SK. Antireflux endoluminal therapies: past and present. Gastroenterol Res Pract. 2013; 2013: 481417.
  60. Fockens P, Cohen L, Edmundowicz SA, et al. Prospective randomized controlled trial of an injectable esophageal prosthesis versus a sham procedure for endoscopic treatment of gastroesophageal reflux disease. Surg Endosc. 2010; 24(6): 1387–1397.
  61. Fockens P, Bruno MJ, Gabbrielli A, et al. Endoscopic augmentation of the lower esophageal sphincter for the treatment of gastroesophageal reflux disease: multicenter study of the Gatekeeper Reflux Repair System. Endoscopy. 2004; 36(8): 682–689.
  62. Al-Ozaibi L, Kazim Y, Hazim W, et al. The Gatekeeper™ for fecal incontinence: Another trial and error. Int J Surg Case Rep. 2014; 5(12): 936–938.
  63. Hajer J, Novák M, Rosina J. Wirelessly Powered Endoscopically Implantable Devices into the Submucosa as the Possible Treatment of Gastroesophageal Reflux Disease. Gastroenterol Res Pract. 2019; 2019: 7459457.
  64. Siersema P, Bredenoord A, Conchillo J, et al. 1085 Electrical Stimulation Therapy (EST) of the Lower Esophageal Sphincter (LES) for Refractory GERD - One Year Results of an International Multicenter Trial. Gastroenterology. 2016; 150(4): S216.
  65. Patel R, Kulkarni P. The Enterra device and the future of gastric electrical pacing. JGDT. 2016; 2(4): 2–5.
  66. Banerjee R, Pratap N, Kalpala R, et al. Effect of electrical stimulation of the lower esophageal sphincter using endoscopically implanted temporary stimulation leads in patients with reflux disease. Surg Endosc. 2014; 28(3): 1003–1009.
  67. Hajer J, Novák M. Development of an Autonomous Endoscopically Implantable Submucosal Microdevice Capable of Neurostimulation in the Gastrointestinal Tract. Gastroenterol Res Pract. 2017; 2017: 8098067.
  68. Hajer J, Novák M. Autonomous and Rechargeable Microneurostimulator Endoscopically Implantable into the Submucosa. J Vis Exp. 2018(139).
  69. DeMarchi J, Schwiers M, Soberman M, et al. Evolution of a novel technology for gastroesophageal reflux disease: a safety perspective of magnetic sphincter augmentation. Dis Esophagus. 2021; 34(11).
  70. Bridges LC, Shillinglaw JP, Smith BE, et al. Augmentation of the Esophageal Sphincter Using LINX. Am Surg. 2022; 88(9): 2170–2175.
  71. Ganz RA, Edmundowicz SA, Taiganides PA, et al. Long-term Outcomes of Patients Receiving a Magnetic Sphincter Augmentation Device for Gastroesophageal Reflux. Clin Gastroenterol Hepatol. 2016; 14(5): 671–677.
  72. Lipham JC, Taiganides PA, Louie BE, et al. Safety analysis of first 1000 patients treated with magnetic sphincter augmentation for gastroesophageal reflux disease. Dis Esophagus. 2015; 28(4): 305–311.
  73. Bona D, Saino G, Mini E, et al. Magnetic sphincter augmentation device removal: surgical technique and results at medium-term follow-up. Langenbecks Arch Surg. 2021; 406(7): 2545–2551.
  74. Bjelović M, Harsányi L, Altorjay Á, et al. Investigators of the RefluxStop™ Clinical Investigation Study Group. Non-active implantable device treating acid reflux with a new dynamic treatment approach: 1-year results : RefluxStop™ device; a new method in acid reflux surgery obtaining CE mark. BMC Surg. 2020; 20(1): 159.
  75. Haugen H, Schneider A, Schlicht H, et al. Long-Term In Vivo Response of a Polyurethane Gastric Implant for Treating Gastro-Oesophageal Reflux Diseases: A Comparison of Different Surface Treatments. Biomedical Materials & Devices. 2022.
  76. Joglekar S, George SV, Leong M. The historical Angelchik anti-reflux device: laparoscopic removal for dysphagia. ANZ J Surg. 2023; 93(1-2): 412–414.
  77. https://www.jnjmedtech.com/en-US/treatment/LINX-reflux-surgery. [accessed 3 Mar, 2023].

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaBy Via Medicav Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl